verapamil has been researched along with tyrosine in 14 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (14.29) | 18.7374 |
1990's | 4 (28.57) | 18.2507 |
2000's | 5 (35.71) | 29.6817 |
2010's | 3 (21.43) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Benson, DW; Fischer, JE; Hasselgren, PO; Hiyama, DT; James, JH; Li, S; Rigel, DF | 1 |
Mastaglia, FL; Steer, JH | 1 |
Santos, DE; Takeuchi, H | 1 |
Cody, DB; Isfort, RJ; LeBoeuf, RA; Ridder, GM; Stuard, SB | 1 |
Elstad, CA; Meadows, GG; Raha, G; Thrall, BD | 1 |
An, RH; Hofmann, F; Ito, H; Kass, RS; Klugbauer, N; Lacinová, L; Triggle, D; Xia, J | 1 |
Abul-Hassan, K; Boulton, M; Tombran-Tink, J; Walmsley, R | 1 |
Hill, MA; Murphy, TV; Spurrell, BE | 1 |
Hoda, JC; Huber, IG; Sinnegger-Brauns, MJ; Striessnig, J; Walter-Bastl, D; Wappl-Kornherr, E | 1 |
Bauer, H; Bauer, HC; Farkas, A; Hutamekalin, P; Krizbai, IA; Nagyoszi, P; Orbók, A; Szatmári, E; Traweger, A; Wejksza, K; Wilhelm, I | 1 |
Arruebo, MP; Grasa, L; Murillo, MD; Plaza, MA | 1 |
Abdelsaid, MA; Al-Gayyar, MM; El-Remessy, AB; Matragoon, S; Pillai, BA | 1 |
Arif Yalcin, A; Biyik, I; Celik, O; Erturk, M; Faruk Akturk, I; Murat Caglar, I; Oner, E; Sarikamis, C; Turhan Caglar, N; Uzun, F | 1 |
1 trial(s) available for verapamil and tyrosine
Article | Year |
---|---|
Effects of verapamil and adenosine in an adjunct to tirofiban on resolution and prognosis of noreflow phenomenon in patients with acute myocardial infarction.
Topics: Adenosine; Aged; Female; Fibrinolytic Agents; Follow-Up Studies; Hospital Mortality; Humans; Male; Middle Aged; Myocardial Infarction; No-Reflow Phenomenon; Percutaneous Coronary Intervention; Prognosis; Prospective Studies; Survival Rate; Tirofiban; Tyrosine; Vasodilator Agents; Verapamil | 2014 |
13 other study(ies) available for verapamil and tyrosine
Article | Year |
---|---|
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Effect of sepsis on calcium uptake and content in skeletal muscle and regulation in vitro by calcium of total and myofibrillar protein breakdown in control and septic muscle: results from a preliminary study.
Topics: Animals; Calcium; Calcium Radioisotopes; Male; Methylhistidines; Muscle Proteins; Muscles; Muscular Diseases; Myofibrils; Rats; Rats, Inbred Strains; Reference Values; Sepsis; Tyrosine; Verapamil | 1989 |
Protein degradation in bupivacaine-treated muscles. The role of extracellular calcium.
Topics: Animals; Bupivacaine; Calcium; Female; Muscle Proteins; Muscles; Rats; Rats, Inbred WF; Tyrosine; Verapamil | 1986 |
Influence of the drugs for membrane excitability modification on the excitation caused by achatin-I.
Topics: Amino Acid Sequence; Animals; Concanavalin A; Drug Interactions; Ion Channels; Membrane Potentials; Molecular Sequence Data; Neurons; Neuropeptides; Picrotoxin; Snails; Tetraethylammonium; Tetraethylammonium Compounds; Tetrodotoxin; Tyrosine; Verapamil | 1993 |
Modulation of the platelet-derived-growth-factor-induced calcium signal by extracellular/intracellular pH in Syrian hamster embryo cells. Implications for the role of calcium in mitogenic signalling.
Topics: Animals; Caffeine; Calcium; Calcium Channel Blockers; Calcium Channels; Cell Division; Cells, Cultured; Cricetinae; Extracellular Space; Hydrogen-Ion Concentration; Inositol 1,4,5-Trisphosphate; Inositol 1,4,5-Trisphosphate Receptors; Intracellular Fluid; Mesocricetus; Mitogens; omega-Conotoxins; Peptides; Phosphorylation; Platelet-Derived Growth Factor; Receptors, Cytoplasmic and Nuclear; Receptors, Platelet-Derived Growth Factor; Tyrosine; Verapamil | 1995 |
Tyrosine and phenylalanine restriction sensitizes adriamycin-resistant P388 leukemia cells to adriamycin.
Topics: Animals; Antineoplastic Agents; Buthionine Sulfoximine; Doxorubicin; Drug Resistance, Neoplasm; Leukemia P388; Melanoma, Experimental; Mice; Phenylalanine; Tumor Cells, Cultured; Tyrosine; Verapamil | 1996 |
Distinctions in the molecular determinants of charged and neutral dihydropyridine block of L-type calcium channels.
Topics: Amino Acid Sequence; Amino Acid Substitution; Calcium Channel Blockers; Calcium Channels; Calcium Channels, L-Type; Cell Line; Cell Membrane; Dihydropyridines; Humans; Isradipine; Kinetics; Membrane Potentials; Models, Molecular; Mutagenesis, Site-Directed; Patch-Clamp Techniques; Protein Structure, Secondary; Recombinant Fusion Proteins; Recombinant Proteins; Threonine; Transfection; Tyrosine; Verapamil | 1999 |
Regulation of tyrosinase expression and activity in cultured human retinal pigment epithelial cells.
Topics: Adjuvants, Immunologic; Aged; alpha-MSH; Calcium Channel Blockers; Carcinogens; Cells, Cultured; Cholera Toxin; Cloning, Molecular; DNA, Complementary; Epithelial Cells; Eye Proteins; Fibroblast Growth Factor 2; Gene Expression Regulation, Enzymologic; Humans; Luciferases; Melanocytes; Methyl Methanesulfonate; Middle Aged; Monophenol Monooxygenase; Mutagens; Nerve Growth Factors; Pigment Epithelium of Eye; Plasmids; Polymerase Chain Reaction; Promoter Regions, Genetic; Protein Processing, Post-Translational; Proteins; RNA Processing, Post-Transcriptional; Serpins; Tetradecanoylphorbol Acetate; Time Factors; Transfection; Tyrosine; Up-Regulation; Uvea; Verapamil | 2000 |
Tyrosine phosphorylation following alterations in arteriolar intraluminal pressure and wall tension.
Topics: Angiotensin II; Animals; Antibody Specificity; Arterioles; Blood Pressure; Calcium; Calcium Channel Blockers; Colforsin; Endothelium, Vascular; In Vitro Techniques; Male; Muscle, Smooth, Vascular; Phosphorylation; Phosphotyrosine; Physical Stimulation; Rats; Rats, Sprague-Dawley; Tyrosine; Tyrphostins; Vanadates; Vasoconstriction; Vasodilator Agents; Verapamil | 2001 |
Opposite effects of a single IIIS5 mutation on phenylalkylamine and dihydropyridine interaction with L-type Ca2+ channels.
Topics: Animals; Brain; Calcium; Calcium Channels; Calcium Channels, L-Type; Carrier Proteins; Cell Membrane; Dihydropyridines; DNA, Complementary; Dose-Response Relationship, Drug; Electrophysiology; Gallopamil; Homozygote; In Situ Hybridization; Isradipine; Kinetics; Mice; Mice, Transgenic; Microsomes; Models, Biological; Mutation; Oocytes; Protein Binding; Protein Structure, Tertiary; Recombinant Proteins; RNA, Complementary; Steroid Isomerases; Tyrosine; Verapamil; Xenopus laevis | 2004 |
Hyperosmotic mannitol induces Src kinase-dependent phosphorylation of beta-catenin in cerebral endothelial cells.
Topics: Animals; beta Catenin; Blood-Brain Barrier; Blotting, Western; Calcium Channel Blockers; Cells, Cultured; Cerebral Cortex; Cytoskeletal Proteins; Diuretics, Osmotic; Endothelial Cells; Enzyme Activation; Enzyme Inhibitors; Fluorescent Antibody Technique; Immunoprecipitation; Mannitol; Osmotic Pressure; Phosphorylation; Rats; src-Family Kinases; Trans-Activators; Tyrosine; Verapamil | 2005 |
The role of tyrosine kinase in prostaglandin E2 and vanadate-evoked contractions in rabbit duodenum in vitro.
Topics: Animals; Calcium; Carbachol; Dinoprostone; Dose-Response Relationship, Drug; Duodenum; Estrenes; Genistein; In Vitro Techniques; Indomethacin; Muscle Contraction; Muscle, Smooth; Phosphorylation; Protein-Tyrosine Kinases; Pyrrolidinones; Rabbits; Tyrosine; Tyrphostins; Vanadates; Verapamil | 2006 |
Thioredoxin interacting protein is a novel mediator of retinal inflammation and neurotoxicity.
Topics: Animals; Apoptosis; Carrier Proteins; Caspase 3; Caspase Inhibitors; Cell Cycle Proteins; Eye Diseases; Inflammation; Interleukin-1beta; Male; MAP Kinase Kinase 4; MAP Kinase Kinase Kinase 5; Neuroglia; Neuroprotective Agents; NF-kappa B; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Rats; Rats, Sprague-Dawley; Retina; Retinal Ganglion Cells; Thioredoxins; Tumor Necrosis Factor-alpha; Tyrosine; Up-Regulation; Verapamil | 2011 |